glp 1 agonists for type 2 diabetes Trends in the Development of GLP-1 Receptor New GLP-1 Guidelines for Type
Description
The phase III SURMOUNT-3 trial by Thomas et al207 evaluated tirzepatide use following intensive lifestyle interventions
As each brand in this space looks at the potential effects of these drugs, they will need to consider clothes sizing to meet new body shapes
XM reviewed the paper and provided suggestions
Nutrition, metabolism, and cardiovascular diseases: NMCD
Concerns have also been expressed regarding a possible link between GLP-1 receptor agonists and medullary thyroid cancer [161]
provided advice on switching between GLP1RAs in clinical practice
